Other languages Cessatech A/S

Equities

CESSA

DK0061411964

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
6.28 ^DKK	-0.95%		+2.95%	-13.50%

Jun. 03	Cessatech A/S Announces Superior Simulated Pain Efficacy in Children Favouring Its Lead Candidate Ct001 Relative to Its Active Comparators	CI
May. 27	Cessatech A/S Reports First Patient Dosed in Final Safety Study 0202 of Lead Product Candidate CT001	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cessatech A/S Announces Superior Simulated Pain Efficacy in Children Favouring Its Lead Candidate Ct001 Relative to Its Active Comparators	Jun. 03
Cessatech A/S Reports First Patient Dosed in Final Safety Study 0202 of Lead Product Candidate CT001	May. 27
Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Cessatech A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16
Cessatech A/S Announces the Paediatric Committee Agrees to Reduce the Number of Required Children in the Final Clinical Study with CT001 from 300 to 150 Children	23-10-25
Cessatech Announces Last Participant Dosed in Pivotal Trial 0205 with Lead Candidate CT001	23-09-21
Cessatech A/S Announces EMA's Paediatric Committee Agrees to Paediatric Investigational Plan for CT002 for Procedural Sedation	23-09-12
Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24
Cessatech A/S and Ventis Pharma Announce US Partnership for CT001	23-06-27
Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-29
Cessatech A/S Appoints Martin Olin as the Chairman of the Board	23-03-23
Cessatech A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-01
Cessatech A/S Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28
Cessatech A/S Auditor Raises 'Going Concern' Doubt	23-02-27
Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-18
Cessatech Reports Successful Outcome of Pharmacokinetic Trial in Children of Lead Candidate	22-09-23
Cessatech A/S Reports First Patient Dosed in Pivotal Trial of Lead Product Candidate	22-09-05
Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19
Cessatech A/S Announces Pivotal Trial 0205 Has Obtained Regulatory Approval	22-06-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cessatech A/S

Equities

CESSA

DK0061411964

Other languages

Filters